These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

556 related articles for article (PubMed ID: 17329029)

  • 41. Paraneoplastic manifestations of renal cell carcinoma.
    Gold PJ; Fefer A; Thompson JA
    Semin Urol Oncol; 1996 Nov; 14(4):216-22. PubMed ID: 8946620
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Renal cell carcinoma: Children's Hospital Boston experience.
    Estrada CR; Suthar AM; Eaton SH; Cilento BG
    Urology; 2005 Dec; 66(6):1296-300. PubMed ID: 16360460
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Protein expression profiles in renal cell carcinoma: staging, prognosis, and patient selection for clinical trials.
    Lam JS; Pantuck AJ; Belldegrun AS; Figlin RA
    Clin Cancer Res; 2007 Jan; 13(2 Pt 2):703s-708s. PubMed ID: 17255297
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In search of a better crystal ball: recent advances in prognostic markers for clear-cell renal cell carcinoma.
    Shah JB; Margulis V
    Expert Rev Anticancer Ther; 2010 Jun; 10(6):837-42. PubMed ID: 20553209
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lessons learned in the surgical management of renal cell carcinoma.
    Sengupta S; Zincke H
    Urology; 2005 Nov; 66(5 Suppl):36-42. PubMed ID: 16194705
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognostic biomarkers in renal cell carcinoma.
    Jiang Z
    Expert Rev Mol Diagn; 2007 May; 7(3):293-307. PubMed ID: 17489736
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adjuvant therapy for renal cell carcinoma.
    Jacobsohn KM; Wood CG
    Semin Oncol; 2006 Oct; 33(5):576-82. PubMed ID: 17045086
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Metastatic renal cell carcinoma: many treatment options, one patient.
    Rini BI
    J Clin Oncol; 2009 Jul; 27(19):3225-34. PubMed ID: 19470934
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Guideline 'Renal cell carcinoma'].
    Mulders PF; Brouwers AH; Hulsbergen-van der Kaa CA; van Lin EN; Osanto S; de Mulder PH
    Ned Tijdschr Geneeskd; 2008 Feb; 152(7):376-80. PubMed ID: 18380384
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Current insights in renal cell cancer pathology.
    Mancini V; Battaglia M; Ditonno P; Palazzo S; Lastilla G; Montironi R; Bettocchi C; Cavalcanti E; Ranieri E; Selvaggi FP
    Urol Oncol; 2008; 26(3):225-38. PubMed ID: 18452811
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic factors for survival in metastatic renal cell carcinoma: update 2008.
    Bukowski RM
    Cancer; 2009 May; 115(10 Suppl):2273-81. PubMed ID: 19402065
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Surgical management of large renal tumors.
    Wszolek MF; Wotkowicz C; Libertino JA
    Nat Clin Pract Urol; 2008 Jan; 5(1):35-46. PubMed ID: 18185512
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Absence of Bcl-2 and Fas/CD95/APO-1 predicts the response to immunotherapy in metastatic renal cell carcinoma.
    Maruyama R; Yamana K; Itoi T; Hara N; Bilim V; Nishiyama T; Takahashi K; Tomita Y
    Br J Cancer; 2006 Nov; 95(9):1244-9. PubMed ID: 17031406
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Natural history of metastatic renal cell carcinoma in patients who underwent consultation for allogeneic hematopoietic stem cell transplantation.
    Nakayama K; Tannir NM; Liu P; Wathen JK; Cheng YC; Champlin RE; Ueno NT
    Biol Blood Marrow Transplant; 2007 Aug; 13(8):975-85. PubMed ID: 17640602
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Translocation renal cell carcinoma: lack of negative impact due to lymph node spread.
    Geller JI; Argani P; Adeniran A; Hampton E; De Marzo A; Hicks J; Collins MH
    Cancer; 2008 Apr; 112(7):1607-16. PubMed ID: 18278810
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Renal cell carcinoma: new developments in molecular biology and potential for targeted therapies.
    Costa LJ; Drabkin HA
    Oncologist; 2007 Dec; 12(12):1404-15. PubMed ID: 18165617
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tumor size does not predict risk of metastatic disease or prognosis of small renal cell carcinomas.
    Klatte T; Patard JJ; de Martino M; Bensalah K; Verhoest G; de la Taille A; Abbou CC; Allhoff EP; Carrieri G; Riggs SB; Kabbinavar FF; Belldegrun AS; Pantuck AJ
    J Urol; 2008 May; 179(5):1719-26. PubMed ID: 18343437
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Factors affecting outcome in renal cell carcinoma.
    Sun M; Shariat SF; Karakiewicz PI
    Curr Opin Urol; 2010 Sep; 20(5):355-60. PubMed ID: 20592610
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vitamin D receptor gene polymorphisms are associated with increased risk and progression of renal cell carcinoma in a Japanese population.
    Obara W; Suzuki Y; Kato K; Tanji S; Konda R; Fujioka T
    Int J Urol; 2007 Jun; 14(6):483-7. PubMed ID: 17593089
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of the association of current cigarette smoking and outcome for patients with clear cell renal cell carcinoma.
    Parker A; Lohse C; Cheville J; Leibovich B; Igel T; Blute M
    Int J Urol; 2008 Apr; 15(4):304-8. PubMed ID: 18380816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.